(FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | 92.28%-443K | -151.95%-5.74M | 11.05M |
Net income from continuing operations | 237.79%1.35M | -51.78%-979K | ---645K |
Operating gains losses | ---- | ---- | --9K |
Depreciation and amortization | -5.26%18K | 58.33%19K | --12K |
Change In working capital | 62.52%-1.83M | -141.98%-4.88M | --11.62M |
-Change in receivables | -507.94%-1.15M | -71.82%-189K | ---110K |
-Change in prepaid assets | -141.18%-123K | -218.75%-51K | ---16K |
-Change in payables and accrued expense | 81.63%-852K | -139.48%-4.64M | --11.74M |
-Change in other current liabilities | --176K | --0 | ---- |
-Change in other working capital | --120K | ---- | ---- |
Cash from discontinued investing activities | |||
Operating cash flow | 92.28%-443K | -151.95%-5.74M | --11.05M |
Investing cash flow | |||
Cash flow from continuing investing activities | 97.37%225K | -67.52%114K | 351K |
Net PPE purchase and sale | 52.94%-8K | 54.05%-17K | ---37K |
Net other investing changes | 77.86%233K | -66.24%131K | --388K |
Cash from discontinued investing activities | |||
Investing cash flow | 97.37%225K | -67.52%114K | --351K |
Financing cash flow | |||
Cash flow from continuing financing activities | -123.36%-341K | 3,141.67%1.46M | -48K |
Net common stock issuance | --0 | --1.52M | --0 |
Net other financing activities | -468.33%-341K | -25.00%-60K | ---48K |
Cash from discontinued financing activities | |||
Financing cash flow | -123.36%-341K | 3,141.67%1.46M | ---48K |
Net cash flow | |||
Beginning cash position | -34.03%8.07M | 1,278.04%12.24M | --888K |
Current changes in cash | 86.58%-559K | -136.69%-4.16M | --11.35M |
End cash Position | -6.92%7.51M | -34.03%8.07M | --12.24M |
Free cash flow | 92.16%-451K | -152.28%-5.76M | --11.01M |
Currency Unit | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- |
No Data